📰 Andreaf Wainer News
Page 28 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
February 6, 2024
Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have been given an average rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month […]
February 6, 2024
Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year target […]
February 6, 2024
NewEdge Wealth LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 55.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,723 shares of the healthcare product maker’s stock after selling 40,036 shares during the quarter. […]
February 6, 2024
Platform Technology Partners trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,571 shares of the healthcare product maker’s stock after selling 473 shares during the quarter. Platform Technology Partners’ […]
February 6, 2024
Greencape Capital Pty Ltd boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 147.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 616,600 shares of the healthcare product maker’s stock after purchasing an additional 367,800 shares during the quarter. […]
February 6, 2024
9258 Wealth Management LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 8.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,502 shares of the healthcare product maker’s stock after selling 1,174 shares during […]
February 6, 2024
Vanguard Personalized Indexing Management LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 115,977 shares of the healthcare product maker’s stock after acquiring an additional 8,262 shares during […]
February 6, 2024
9258 Wealth Management LLC decreased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,502 shares of the healthcare product maker’s stock after selling 1,174 shares during the period. 9258 […]
February 6, 2024
Tealwood Asset Management Inc. lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,175 shares of the healthcare product maker’s stock after acquiring an additional 303 shares during the quarter. Tealwood […]
February 4, 2024
Trillium Asset Management LLC trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 19.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 7,627 shares of the healthcare product maker’s stock after selling 1,809 shares during the period. Trillium Asset Management LLC’s holdings in Abbott Laboratories were worth $739,000 at the end […]